GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnax Lab Ltd (BOM:506128) » Definitions » Gross Margin %

Parnax Lab (BOM:506128) Gross Margin % : 41.39% (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Parnax Lab Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Parnax Lab's Gross Profit for the three months ended in Dec. 2023 was ₹211 Mil. Parnax Lab's Revenue for the three months ended in Dec. 2023 was ₹510 Mil. Therefore, Parnax Lab's Gross Margin % for the quarter that ended in Dec. 2023 was 41.39%.

Warning Sign:

Parnax Lab Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.6%.


The historical rank and industry rank for Parnax Lab's Gross Margin % or its related term are showing as below:

BOM:506128' s Gross Margin % Range Over the Past 10 Years
Min: 24.13   Med: 30.39   Max: 34.81
Current: 30


During the past 13 years, the highest Gross Margin % of Parnax Lab was 34.81%. The lowest was 24.13%. And the median was 30.39%.

BOM:506128's Gross Margin % is ranked worse than
77.48% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.51 vs BOM:506128: 30.00

Parnax Lab had a gross margin of 41.39% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Parnax Lab was -1.60% per year.


Parnax Lab Gross Margin % Historical Data

The historical data trend for Parnax Lab's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnax Lab Gross Margin % Chart

Parnax Lab Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.81 30.19 32.81 29.45 30.59

Parnax Lab Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.85 -20.36 43.51 49.26 41.39

Competitive Comparison of Parnax Lab's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Parnax Lab's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parnax Lab's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnax Lab's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Parnax Lab's Gross Margin % falls into.



Parnax Lab Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Parnax Lab's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=512.7 / 1676.069
=(Revenue - Cost of Goods Sold) / Revenue
=(1676.069 - 1163.37) / 1676.069
=30.59 %

Parnax Lab's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=211 / 509.886
=(Revenue - Cost of Goods Sold) / Revenue
=(509.886 - 298.861) / 509.886
=41.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Parnax Lab  (BOM:506128) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Parnax Lab had a gross margin of 41.39% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Parnax Lab Gross Margin % Related Terms

Thank you for viewing the detailed overview of Parnax Lab's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Parnax Lab (BOM:506128) Business Description

Traded in Other Exchanges
N/A
Address
104 - 107, Building No. 8, Gala No. 114, Jogani Industrial Complex, Panchsheel Nagar, Next to Modi Hyundai Service Centre, Chunabhatti, Sion, Mumbai, MH, IND, 400 022
Parnax Lab Ltd is principally engaged in the manufacturing and export of Pharmaceutical Formulations. Its product categories include Pharmaceuticals; Cosmetics; Herbal and Nutraceuticals. The company is developing and delivering Oral Formulations such as Cough Expectorants, Antacids, Anti-Histamines, Multi-Vitamins, Enzyme Preparations, Pediatric Formulations, Special Formulations for Geriatrics, Highly Viscous Products, Suspensions, and others.

Parnax Lab (BOM:506128) Headlines

No Headlines